Post stroke depression: Clinics, etiopathogenesis and therapeutics

Revista de Psiquiatria Clinica

Volumn 42, Issue 1, 2015, Pages 18-24

  Pedroso, Vinicius Sousa Pietra ^a   de Souza, Leonardo Cruz ^a   Brunoni, Andre R ^b   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cerebrovascular diseases; Depression; Post stroke depression; Stroke; Vascular depression

Indexed keywords

CITALOPRAM; FLUOXETINE; METHYLPHENIDATE; MILNACIPRAN; MIRTAZAPINE; NORTRIPTYLINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ARTICLE; BRAIN DEPTH STIMULATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DEPRESSION; HEALTH PROGRAM; HEART RATE VARIABILITY; HUMAN; META ANALYSIS (TOPIC); MORBIDITY; PATHOPHYSIOLOGY; POST STROKE DEPRESSION; PROGNOSIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW (TOPIC);

EID: 84926370631     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/0101-60830000000041     Document Type: Article

References (60)

1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6-e245.
2. de Carvalho JJ, Alves MB, Viana GA, Machado CB, dos Santos BF, Ka-namura AH, et al. Stroke epidemiology, patterns of management, and outcomes in Fortaleza, Brazil: a hospital-based multicenter prospective study. Stroke. 2011;42(12):3341-6.
3. Angelelli P, Paolucci S, Bivona U, Piccardi L, Ciurli P, Cantagallo A, et al. Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study. Acta Psychiatr Scand. 2004;110(1):55-63.
4. Robinson RG. The clinical neuropsychiatry of stroke. New York: Cambridge University Press; 2006.
5. Folstein MF, Maiberger R, McHugh PR. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry. 1977;40(10):1018-20.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
7. Ayerbe L, Ayis S, Wolfe CD, Rudd AG. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry. 2013;202(1):14-21.
8. Ayerbe L, Ayis S, Crichton S, Wolfe CD, Rudd AG. The natural history of depression up to 15 years after stroke: the South London Stroke Register. Stroke. 2013;44(4):1105-10.
9. Fróes KS, Valdés MT, Lopes Dde P, Silva CE. Factors associated with health-related quality of life for adults with stroke sequelae. Arq Neu-ropsiquiatr. 2011;69(2B):371-6.
10. Souza AC, Rocha MO, Teixeira AL, Dias Júnior JO, Sousa LA, Nunes MC. Depressive symptoms and disability in chagasic stroke patients: impact on functionality and quality of life. J Neurol Sci. 2013;324(1-2):34-7.
11. Carod-Artal FJ, Trizotto DS, Coral LF, Moreira CM. Determinants of quality of life in Brazilian stroke survivors. J Neurol Sci. 2009;284(1-2):63-8.
12. Simis S, Nitrini R. Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke. Arq Neuropsiquiatr. 2006;64(2B):412-7.
13. Terroni LM, Fráguas R, Lucia M, Tinone G, Mattos P, Iosifescu DV, et al. Importance of retardation and fatigue/interest domains for the diagnosis of major depressive episode after stroke: a four months prospective study. Rev Bras Psiquiatr. 2009;31(3):202-7.
14. Schefer M, Monteiro JK, de Almeida RMM. Frontal stroke: problem solving, decision making, impulsiveness, and depressive symptoms in men and women. Psychol Neurosci. 2011;4(2):267-78.
15. Rangel ESS, Belasco AGS, Diccini S. Qualidade de vida de pacientes com acidente vascular cerebral em reabilitação. Acta Paul Enferm. 2013;26(2):205-12.
16. Clarke DM, Kissane D W. Demoralization: its phenomenology and importance. Aust NZJ Psychiatry. 2002;36(6):733-42.
17. Shader RI. Demoralization revisited. J Clin Psychopharmacology. 2005;25(4):291-2.
18. Spalletta G, Robinson RG. How should depression be diagnosed in patients with stroke? Acta Psychiatr Scand. 2010;121(6):401-3.
19. Fedorof J P, Starkstein SE, Parikh RM, Price TR, Robinson RG. Are depressive symptoms nonspecific in patients with acute stroke? Am J Psychiatry. 1991;148(9):1172-6.
20. Cumming TB, Churilov L, Skoog I, Blomstrand C, Linden T. Little evidence for different phenomenology in poststroke depression. Acta Psychiatr Scand. 2010;121(6):424-30.
21. Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major poststroke depression. Br J Psychiatry. 1999;175:163-7.
22. Kauhanen M, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Määttä R, et al. Poststroke depression correlates with cognitive impairment and neurological defcits. Stroke. 1999;30(9):1875-80.
23. Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Kappelle LJ. Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. J Neurol Sci. 2005;228(1):27-33.
24. Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Jansen B P, et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke. J Neurol Sci. 2006;247(2):149-56.
25. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: a systematic review. Lancet. 2000;356(9224):122-6.
26. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. Vascular depression hypothesis. Arch Gen Psychiatry. 1997;54(10):915-22.
27. Robinson RG, Bloom FE. Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke. Biol Psychiatry. 1977;12(5):669-80.
28. Bryer JB, Starkstein SE, Votypka V, Parikh RM, Price TR, Robinson RG. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report. J Neuropsychiatry Clin Neurosci. 1992;4(4):440-2.
29. Moller M, Andersen G, Gjedde A. Serotonin 5-HT1a receptor availability and pathological crying after stroke. Acta Neurol Scand. 2007;116(2):83-90.
30. Spalletta G, Bossu P, Ciaramella A, Bria P, Caltagirone C, Robinson RG. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry. 2006;11(11):984-91.
31. Mossner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC, Müller N, et al. Consensus paper of the WFSBP Task Force on Biological Markers: Biological markers in depression. W J Biol Psych. 2007;8(3):141-74.
32. Fábregas BC, Vitorino FD, Rocha DM, Moura AS, Carmo RA, Teixeira AL. Screening inventories to detect depression in chronic hepatitis C patients. Gen Hosp Psychiatry. 2012;34(1):40-5.
33. O’Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, et al. Lip opolys accharide-induce d depressive-like behavior is mediated by indolea-mine 2,3-dioxygenase activation in mice. Mol Psychiatry. 2009;14(5):511-22.
34. Craf TK, DeVries AC. Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry. 2006;15;60(8):812-8.
35. Jiménez I, Sobrino T, Rodríguez-Yáñez M, Pouso M, Cristobo I, Sabuce-do M, et al. High serum levels of leptin are associated with post-stroke depression. Psychol Med. 2009;39(7):1201-9.
36. Yang L, Zhang Z, Sun D, Xu Z, Zhang X, Li L. The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol Res. 2010;32(4):340-6.
37. Spalletta G, Cravello L, Imperiale F, Salani F, Bossù P, Picchetto L, et al. Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci. 2013;25(4):255-63.
38. Ramasubbu R, Tobias R, Buchan AM, Bech-Hansen NT. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. J Neuropsychiatry Clin Neurosci. 2006;18(1):96-9.
39. Kohen R, Cain KC, Buzaitis A, Johnson V, Becker KJ, Teri L, et al. Response to psychosocial treatment in poststroke depression is associated with serotonin transporter polymorphisms. Stroke. 2011;42(7):2068-70.
40. Kim JM, Stewart R, Bae KY, Kim S W, Kang HJ, Shin IS, et al. Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord. 2012;136(3):833-40.
41. Zhou Z, Lu T, Xu G, Yue X, Zhu W, Ma M, et al. Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clin Chem Lab Med. 2011;49(2):185-9.
42. Tang WK, Tang N, Liao CD, Liang HJ, Mok VC, Ungvari GS, et al. Serotonin receptor 2C gene polymorphism associated with post-stroke depression in Chinese patients. Genet Mol Res. 2013;12(2):1546-53.
43. Kim JM, Stewart R, Kim SW, Shin IS, Kim JT, Park MS, et al. Associations of cytokine gene polymorphisms with post-stroke depression. World J Biol Psychiatry. 2012;13(8):579-87.
44. Lieberman D, Friger M, Fried V, Grinshpun Y, Mytlis N, Tylis R, et al. Characterization of elderly patients in rehabilitation: stroke versus hip fracture. Disabil Rehabil. 1999;21(12):542-7.
45. Bozikas V P, Gold G, Kovari E, Herrmann F, Karavatos A, Giannakopoulos P, et al. Pathological correlates of poststroke depression in elderly patients. Am J Geriatr Psychiatry. 2005;13(2):166-9.
46. Oldehinkel AJ, Ormel J, Brilman EI, van den Berg MD. Psychoso-cial and vascular risk factors depression in later life. J Affect Disord. 2003;74(3):237-46.
47. Paolucci S, Gandolfo C, Provinciali L, Torta R, Toso V; DESTRO Study Group. The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol. 2006;253(5):556-62.
48. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(6):1330-40.
49. Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry. 1999;175:163-7.
50. Robinson RG, Spalletta G, Jorge RE, Bassi A, Colivicchi F, Ripa A, et al. Decreased heart rate variability is associated with poststroke depression. Am J Geriatr Psychiatry. 2008;16(11):867-73.
51. Tokgozoglu SL, Batur MK, Topcuoglu MA, Saribas O, Kes S, Oto A. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke. 1999;30(7):1307-11.
52. Makikallio AM, Makikallio TH, Korpelainen JT, Sotaniemi KA, Huikuri H V, Myllylä VV. Heart rate dynamics predict poststroke mortality. Neurology. 2004;62(10):1822-6.
53. Hackett ML, Anderson CS, House AO, Xia J. Interventions for treating depression afer stroke. Stroke. 2009;40(7):e487-8.
54. Price A, Rayner L, Okon-Rocha E, Evans A, Valsraj K, Higginson IJ, et al. Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry. 2011;82(8):914-23.
55. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;(3):CD003689.
56. Chollet F, Tardy J, Albucher JF, Talamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10(2):123-30.
57. Mead GE, Hsieh CF, Lee R, Kutlubaev M, Claxton A, Hankey GJ, et al. Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke. 2013;44(3):844-50.
58. Kim BR, Kim DY, Chun MH, Yi JH, Kwon JS. Effect of repetitive transcranial magnetic stimulation on cognition and mood in stroke patients: a double-blind, sham-controlled trial. Am J Phys Med Rehabil. 2010;89(5):362-8.
59. Jorge RE, Moser DJ, Acion L, Robinson RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2008;65(3):268-76.
60. Bueno VF, Brunoni AR, Boggio PS, Bensenor IM, Fregni F. Mood and cognitive effects of transcranial direct current stimulation in post-stroke depression. Neurocase. 2011;17(4):318-22.